Protective efficacy of aTreponema pallidumGpd DNA vaccine vectored by chitosan nanoparticles and fused with interleukin-2
- 1 February 2012
- journal article
- Published by Canadian Science Publishing in Canadian Journal of Microbiology
- Vol. 58 (2) , 117-123
Abstract
In the present study, immunomodulatory responses of a DNA vaccine constructed by fusing Treponema pallidum (Tp) glycerophosphodiester phosphodiesterase (Gpd) to interleukin-2 (IL-2) and using chitosan (CS) nanoparticles as vectors were investigated. New Zealand white rabbits were immunized by intramuscular inoculation of control DNAs, Tp Gpd DNA vaccine, or Gpd-IL-2 fusion DNA vaccine, which were vectored by CS nanoparticles. Levels of the anti-Gpd antibodies and levels of IL-2 and interferon-γ in rabbits were increased upon inoculation of Gpd-IL-2 fusion DNA vaccine, when compared with the inoculation with Gpd DNA vaccine, with CS vectoring increasing the effects. The Gpd-IL-2 fusion DNA vaccine efficiently enhanced the antigen-specific lymphocyte proliferative response. When the rabbits were challenged intradermally with 10(5) Tp (Nichols) spirochetes, the Gpd-IL-2 fusion DNA vaccine conferred better protection than the Gpd DNA vaccine (P < 0.05), as characterized by lower detectable amounts of dark field positive lesions (17.5%), lower ulcerative lesion scores (15%), and faster recovery. Individuals treated with the Tp Gpd-IL-2 fusion DNA vaccine vectored by CS nanoparticles had the lowest amounts of dark field positive lesions (10%) and ulcerations (5%) observed and the fastest recovery (42 days). These results indicate that the Gpd-IL-2 fusion DNA vaccine vectored by CS nanoparticles can efficiently induce Th1-dominant immune responses, improve protective efficacy against Tp spirochete infection, and effectively attenuate development of syphilitic lesions.Keywords
This publication has 15 references indexed in Scilit:
- Immune Responses and Therapeutic Antitumor Effects of an Experimental DNA Vaccine Encoding Human Papillomavirus Type 16 Oncoproteins Genetically Fused to Herpesvirus Glycoprotein DClinical and Vaccine Immunology, 2010
- Strong HIV-Specific CD4 + and CD8 + T-Lymphocyte Proliferative Responses in Healthy Individuals Immunized with an HIV-1 DNA Vaccine and Boosted with Recombinant Modified Vaccinia Virus Ankara Expressing HIV-1 GenesClinical and Vaccine Immunology, 2010
- Enhancement of immunity to an Escherichia coli vaccine in mice orally inoculated with a fusion gene encoding porcine interleukin 4 and 6Vaccine, 2007
- Porcine interleukin-2 gene encapsulated in chitosan nanoparticles enhances immune response of mice to piglet paratyphoid vaccineComparative Immunology, Microbiology and Infectious Diseases, 2007
- Biological Basis for SyphilisClinical Microbiology Reviews, 2006
- A novel HBV DNA vaccine based on T cell epitopes and its potential therapeutic effect in HBV transgenic miceInternational Immunology, 2005
- Immunization with the N-Terminal Portion ofTreponema pallidumRepeat Protein K Attenuates Syphilitic Lesion Development in the Rabbit ModelInfection and Immunity, 2002
- Opsonic Potential, Protective Capacity, and Sequence Conservation of theTreponema pallidumsubspeciespallidumTp92The Journal of Infectious Diseases, 2000
- Identification of the Treponema pallidum subsp. pallidum glycerophosphodiester phosphodiesterase homologueFEMS Microbiology Letters, 1997
- Macrophage-Mediated Killing of Opsonized Treponema pallidumThe Journal of Infectious Diseases, 1992